NasdaqGM - Delayed Quote USD
Altimmune, Inc. (ALT)
4.9700
+0.1200
+(2.47%)
At close: April 23 at 4:00:01 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
DRUTZ DAVID J Director | Sale | Aug 19, 2024 | -- |
EISENSTADT RICHARD I Chief Financial Officer | Stock Award(Grant) | Jan 31, 2024 | 45,012 |
GARG VIPIN K. Chief Executive Officer | Conversion of Exercise of derivative security | Jan 31, 2025 | 355,082 |
HARRIS MATTHEW SCOTT Officer | Stock Gift | Mar 7, 2025 | 81,856 |
JORDT RAYMOND M Officer | Stock Award(Grant) | Jan 31, 2025 | 34,902 |
ROBERTS M SCOT Officer | Conversion of Exercise of derivative security | Jan 31, 2025 | 73,220 |
SHUTTERLY ANDREW Chief Financial Officer | Stock Award(Grant) | Jul 31, 2024 | 11,372 |
SOHN CATHERINE A Director | Purchase | Mar 17, 2025 | 1,000 |
WEAVER GREGORY L Chief Financial Officer | Purchase | Mar 13, 2025 | 10,000 |
Related Tickers
TERN Terns Pharmaceuticals, Inc.
2.8800
+2.86%
GPCR Structure Therapeutics Inc.
23.32
+1.22%
VKTX Viking Therapeutics, Inc.
25.79
+1.22%
MDGL Madrigal Pharmaceuticals, Inc.
308.79
+2.01%
IOVA Iovance Biotherapeutics, Inc.
3.1900
-0.62%
MCRB Seres Therapeutics, Inc.
9.73
+19.24%
CADL Candel Therapeutics, Inc.
4.7600
+0.53%
IBRX ImmunityBio, Inc.
2.6900
0.00%
IMUX Immunic, Inc.
1.1000
+10.00%
CAPR Capricor Therapeutics, Inc.
13.15
-5.33%